| [1] |
Andrade SE，Gurwitz JH，Davis RL，et al. Prescription drug use in pregnancy[J]. Am J Obstet Gynecol，2004，191(2)：398–407.
|
| [2] |
Ceckova-Novotna M，Pavek P，Staud F. P-glycoprotein in the placenta: expression, localization，regulation and function[J]．Reprod Toxicol，2006，22(3)：400–410.
|
| [3] |
Holcberg G，Sapir O，Tsadkin M，et al.Lack of interaction of digoxin and P-glycoprotein inhibitors，quinidine and verapamil in human placenta in vitro[J]. Eur J Obstet Gynecol Reprod Biol，2003，109(2)：133–137.
|
| [4] |
Wang C，Li H，Zhou K，et al. Sodium tanshinone ⅡA sulfonate and sodium danshensu open the placental barrier through down-regulation of placental P-glycoprotein in mice: implications in the transplacental digoxin treatment for fetal heart failure[J]．Int J Cardiol，2014，176(3)：1331–1333.
|
| [5] |
Anger GJ，Cressman AM，Piquette-Miller M. Expression of ABC Efflux transporters in placenta from women with insulin-managed diabetes[J]．PLoS One，2012，7(4)：e35027.
|
| [6] |
Soo PS，Hiscock J，Botting KJ，et al.Maternal undernutrition reduces P-glycoprotein in guinea pig placenta and developing brain in late gestation[J]．Reprod Toxicol，2012，33(3)：374–381.
|
| [7] |
Lumeng CN，Bodzin JL，Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization[J]．J Clin Invest，2007，117(1)：175–184.
|
| [8] |
Challier JC，Basu S，Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta[J]. Placenta，2008，29(3)：274–281.
|
| [9] |
Ramsay JE，Ferrell WR，Crawford L，et al. Maternal obesity is associated with dysregulation of metabolic，vascular，and inflammatory pathways[J]．J Clin Endocrinol Metab，2002，87(9)：4231–4237.
|
| [10] |
Evseenko DA，Paxton JW，Keelan JA.Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors[J]．Drug Metab Dispos，2007，35(4)：595–601.
|
| [11] |
Petrovic V，Piquette-Miller M．Impact of polyinosinic/polycytidylic acid on placental and hepatobiliary drug transporters in pregnant rats[J]. Drug Metab Dispos，2010，38(10)：1760–1766.
|
| [12] |
Zatelli MC，Molè D，Tagliati F，et al. Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB[J]. Cell Oncol，2009，31(6)：457–465.
|
| [13] |
Cygalova L，Ceckova M，Pavek P，et al. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat[J]. Toxicol Lett, 2008, 178(3)：176–180.
|
| [14] |
Scotto KW.Transcriptional regulation of ABC drug transporters[J]. Oncogene, 2003，22(47)：7496–7511.
|
| [15] |
Sukhai M，Yong A，Pak A，et al.Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes[J]．Inflamm Res，2001，50(7)：362–370.
|
| [16] |
张洁，王方，许海燕，等．炎性因子与胰岛素抵抗[J]．世界华人消化杂志，2006，14(32): 3121–3125.
|
| [17] |
Liu H，Yang H，Wang D，et al.Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappa B pathway but not a PI3K/Akt pathway[J]．Eur J Pharmacol，2009，602(2-3)：277–282.
|
| [18] |
Zhou SF.Structure，function and regulation of P-glycoprotein and its clinical relevance in drug disposition[J]．Xenobiotica，2008，38(7-8)：802–832.
|
| [19] |
Gulati A，Gerk PM. Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy[J]．J Pharm Sci，2009，98(7)：2317–2335.
|
| [20] |
Zhou K，Zhou R，Zhu Q，et al.Evaluation of therapeutic effect and cytokine change during transplacental Digoxin treatment for fetal heart failure associated with fetal tachycardia，a case-control study[J]．Int J Cardiol，2013，169(4)：e62–e64.
|
| [21] |
Zhou KY，Hua YM，Zhu Q. Transplacental digoxin therapy for fetal atrial flutter with hydrops fetalis[J]. World J Pediatr，2012，8(3)：275–277.
|
| [22] |
Lankas GR，Wise LD，Cartwright ME，et al. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice[J]．Reprod Toxicol，1998，12(4)：457–463.
|
| [23] |
Wang C，Xie L，Zhou K，et al.Increased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposure[J]．PLoS One，2013，8(7)：e68807.
|